IMC Chicago’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
IMC Chicago's BMRN Position: Q3 2026 in Review
IMC Chicago increased its BioMarin Pharmaceuticals (BMRN) stake by 22% in Q3 2026, buying an estimated $129K and bringing the position to 11,512 shares worth $691K. The position accounts for ﹤0.01% of the portfolio, ranked #4335.
IMC Chicago first reported a position in BMRN in Q4 2018 and has held it in 7 quarters since. The position peaked at $1.82M in Q1 2021. 567 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- IMC Chicago held 11,512 shares of BioMarin Pharmaceuticals worth $691K as of Q3 2026.
- IMC Chicago bought 2,045 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $129K.
- BioMarin Pharmaceuticals made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #4335 holding.
- IMC Chicago first reported a position in BioMarin Pharmaceuticals in Q4 2018 and has held it in 7 quarters since.
- IMC Chicago's BioMarin Pharmaceuticals position peaked at $1.82M in Q1 2021.
- 567 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.